Syngene
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Beacon House Nuffield Rd, Cambridge, Cam...Phone Number
(800) 686-4407Website
www.syngene.comRevenue
$12 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Syngene
Founded in 1997, Syngene is a world-leading supplier of gel doc systems, providing rapid imaging and accurate analysis of various gel types for molecular biologists and scientists. Their products are utilized in Life Sciences, Genomics, and Proteomics applications globally, serving many top academic research institutes and pharmaceutical companies. Syngene offers a range of imaging systems, including Chemiluminescence and Fluorescence systems, ensuring reliable analysis of proteins and nucleic acids. Their collaboration with AirClean also establishes high-quality PCR workstations aimed at enhancing safety and reducing contamination in laboratories.Explore more
Syngene Org Chart
PN
Biotechnology Specialist
GS
Researcher
MM
Research Scientist
HU
Research Scientist
AK
Research & Development Assistant
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Syngene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Syngene
Click to see if Syngene had a recent Job posting/layoffs
Earning: See what the market has to say on Syngene recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Syngene is spiking on competitors!
Syngene, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Syngene has new funding data
Product Launch: Get notified when Syngene launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Syngene has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Syngene as Masked Content
Find 3 more new buyers
Compare Similar Companies to Syngene
Compare insights from companies similar to Syngene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Syngene is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Syngene is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Syngene.
Syngene Tech Stack
A closer look at the technologies used by Syngene
Syngene News & Media
Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
As previously announced on July 4, 2023, Syngene International has completed the acquisition of a multi-modal biologics production plant from Stelis Biopharma Ltd. After revisions to the original gross value of Rs 702 crores, the acquisition of the biologics production facility known as "Unit 3" was finalised at a revised gross value of Rs 617 crores.The retention of some equipment that Stelis Biopharma Ltd. does not currently have installed in the plant is reflected inSyngene International signs 10-year agreement with US-based firm Zoetis
Librela or bedinvetmab has already been launched in Europe and the UK, and has won 'Best new companion animal product' by IHS Markit Connect in 2021Syngene To Acquire 26% Stake In Ampyr Renewable Energy Resources Eleven
Syngene International said it will acquire 26 percent stake in Ampyr Renewable Energy Resources Eleven Private Ltd.Biocon arm Syngene ends contract with Bioinnovat Research over graft case
Guljit Sethi of Bioinnovat was named in CBI FIR on a bribery case involving CDSCO official and Biocon Biologics executive
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Syngene
Sign Up For FreeTo access detailed company insights
Founded in 1997, Syngene is a world-leading supplier of gel doc systems, providing rapid imaging and accurate analysis of various gel types for molecular biologists and scientists. Their products are utilized in Life Sciences, Genomics, and Proteomics applications globally, serving many top academic research institutes and pharmaceutical companies.... Read More
